Accelerator Life Science Partners
VC
INVESTOR TYPE
Active
STATUS
5
PROFESSIONALS
27
INVESTMENTS
13
PORTFOLIO
9
EXITS
Description
Founded in 2003, Accelerator Life Science Partners is a venture capital firm based in Seattle, Washington. The firm identifies, evaluates, finances, and manages the commercialization of technologies and assets sourced from a broad range of proprietary sources. The firm provides a set of start-up resources, the sum of which provide a complete business, scientific, and financial toolkit necessary for running an early-stage biotech company.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2003
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- 430 East 29th Street
- Suite 840
- New York, NY 10016
- United States
+1 (646) 000-0000
Accelerator Life Science Partners Investments (27)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Proniras | 11-Jul-2019 | Early Stage VC | 00.00 | Biotechnology | Startup | 00000 00 |
| 000000 00000000000 | 23-Aug-2018 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 00 |
| 00000000 000000000 | 13-Aug-2018 | 00000 00000 | 0000 | Drug Discovery | Startup | 00000 00 |
| 00000 | 11-Dec-2017 | 0000 00000 | 00.00 | Other Services (B2C Non-Financial) | Generating Revenue | |
| 00000 000000000000 | 25-Jul-2017 | 00000 00000 | 00.00 | Biotechnology | Generating Revenue | 00000 00000000 |
| 0000 000000000000 | 18-Jan-2016 | 00000 00000 | 000.00 | Drug Discovery | Startup | 00000 00 |
| 00000 000000 | 06-Jan-2016 | 00000 00000 | 0000 | Biotechnology | Startup | 00000 00 |
| 000000 00000000000 | 02-Jul-2014 | 000000000 00 | 00.000 | Drug Discovery | Generating Revenue | 0000 00000000 |
| Theraclone Sciences | 12-Aug-2013 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | |
| Hello English | 22-May-2013 | Seed Round | Educational Software | Startup |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Accelerator Life Science Partners’s full profile, request a free trial.
Accelerator Life Science Partners Exits (9)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Integrated Diagnostics | 09-Jul-2018 | Merger/Acquisition | Completed | ||
| 000000 000000 | 18-Nov-2016 | 000 00 00000000 | Completed |
|
|
| 000000000 00000 | 30-Sep-2016 | 000000000000000000 | 00000 | Completed |
|
| 00000000 | 01-Jan-2014 | 000000000000000000 | Completed |
|
|
| 00000000 | 23-Nov-2009 | 000 00 00000000 | Completed |
|
|
| 000000000 | 12-Jun-2009 | 000 00 00000000 | Completed |
|
|
| 000000 | 04-Jan-2007 | 000 00 00000000 | Completed |
|
|
| Oncofactor | Out of Business | Completed |
|
||
| PharmSelex | Bankruptcy: Liquidation | Completed |
|
Accelerator Life Science Partners Team (18)
3 Former Team Members
You’re viewing 5 of 18 team members. Get the full list »Accelerator Life Science Partners Co-Investors (24)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| ARCH Venture Partners | 6 | 0 | |
| Alexandria Venture Investments | 0 | 0 | |
| Watson Fund | 0 | 0 | |
| WuXi AppTec | 0 | 0 | |
| Johnson & Johnson Innovation - JJDC | 0 | 0 |